Wegovy targets weight management, starting also at 0.25mg before stepping up to a maintenance dose of 2.4mg at a weekly schedule
The hospital setting is particularly significant for patients with complex comorbidities, necessitating a multidisciplinary approach to treatment, including diabetes education and lifestyle modification alongside pharmacotherapy
For hip injuries including bursitis, tendinopathy, and soft tissue damage, typical protocols involve 0.25 to 0.5 mg daily via subcutaneous injection near the affected area for 4 to 8 weeks
"I did, and I'm really happy with it."
The Evidence: Meal Replacements as GLP-1 Allies Research shows combining meal replacements with GLP-1s enhances outcomes: Increased Weight Loss : Studies indicate 12% greater weight reduction when MR (1-3 meals/day) is added to GLP-1 therapy, thanks to structured calories and satiety